India’s laissez-faire attitude to drug regulation is a serious threat to global efforts to tackle antimicrobial resistance.
- Reader in Clinical Pharmacology and Medical Education, Queen Mary University of London
Combination drugs are considered an innovation of India’s medicines industry but they are not as safe as they should be.
Contact Patricia for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
- Website
- Article Feed
- ORCID
- Joined
